Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;11(4):231-8.
doi: 10.2174/1573399811666150421114146.

Developmental changes in the roles of patients and families in type 1 diabetes management

Affiliations
Review

Developmental changes in the roles of patients and families in type 1 diabetes management

Jessica T Markowitz et al. Curr Diabetes Rev. 2015.

Abstract

Developmentally-tailored diabetes self-care education and support are integral parts of contemporary multidisciplinary T1D care. The patient with T1D must have the support of the family and the diabetes team to maintain the rigors of diabetes management, but the specific roles of patients and families with regard to daily diabetes tasks change considerably throughout the developmental span of early childhood, middle childhood/school-age years, and adolescence. This review provides a framework of key normative developmental issues for each of these developmental stages. Within this context, ideal family diabetes management is reviewed within each developmental stage and anticipated challenges that can arise during these stages and that can adversely impact diabetes management are presented. This paper also summarizes empirical evidence for specific intervention and care strategies to support optimal diabetes management across these stages in order to maximize opportunities for a successful transfer of diabetes management tasks from parents to maturing youth. Finally, the review provides an emphasis on approaches to promote family teamwork and adolescent diabetes self-care adherence as well as opportunities to use novel technology platforms as a means to support optimal diabetes management.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:

Dr. Markowitz and Dr. Garvey have no have no conflicts of interest to disclose. Dr. Laffel has no conflicts of interest associated with this report. Dr. Laffel reports that she serves as a consultant for Johnson & Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Astra-Zeneca, Menarini, Lifescan/Animas, Roche, Oshadi, Bayer Healthcare, NovoNordisk, DexCom, and Boehringer Ingelheim. This work was partially supported by NIH/NIDDK 1K23DK092335; 1K23DK102655; K12DK094721 and P30DK036836

Similar articles

Cited by

References

    1. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993 Jul 29;329(5):304–9. - PubMed
    1. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr. 1994 Aug;125(2):177–88. - PubMed
    1. The Writing Team for the Diabetes Control and Complications Trial-Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002 May 15;287(19):2563–9. - PMC - PubMed
    1. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003 Jun 5;348(23):2294–303. - PMC - PubMed
    1. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005 Dec 22;353(25):2643–53. - PMC - PubMed

Publication types